Literature DB >> 31593685

Extracellular lysine 38 plays a crucial role in pH-dependent transport via human monocarboxylate transporter 1.

Atsushi Yamaguchi1, Yuya Futagi2, Masaki Kobayashi3, Katsuya Narumi1, Ayako Furugen1, Ken Iseki4.   

Abstract

Human monocarboxylate transporters (hMCTs) are expressed in many tissues and mediate the transport of various substrates across the plasma membrane. Among hMCTs, hMCT1-4 cotransport H+ with monocarboxylates such as pyruvate and l-lactate, implying that these proteins recognize both substrate and H+. However, the mechanism of translocation, and particularly that of hMCT1 pH-dependent transport, remains largely unknown. This study aimed at identifying residues involved in the pH dependence of hMCT1 using a combination of amino acid-modifying reagents, site-directed mutagenesis in a Xenopus laevis oocyte expression system, and homology modeling. We showed that diethyl pyrocarbonate (DEPC), phenylglyoxal (PGO), and 4,4'-diisothiocyanato-2,2'-stilbenedisulfonic acid disodium salt (DIDS), which react with histidine, arginine, and lysine residues respectively, all inhibited hMCT1 activity. Since DEPC, PGO, and DIDS are membrane impermeable reagents, we mutated to other residues individual histidine, arginine, and lysine residues located within the extracellular regions of hMCT1. Analyses of these mutants demonstrated that except for K38, the extracellular basic residues of hMCT1 were not involved in its transport activity and pH dependence. Moreover, analyses of various mutants in which K38 was substituted for another residue and of an hMCT1 homology model focusing on the location of K38 in the three-dimensional structure delineated the mechanism of hMCT1 pH dependence. Collectively, our data indicate that K38 plays an essential role in hMCT1 transport activity. We would like to propose a mechanism whereby K38 is positioned within a hydrophobic and narrow cavity that is part of the transport pathway, and regulates pH-dependent gating of hMCT1.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemical modification; Homology model; Monocarboxylate transporter; Site-directed mutagenesis; Xenopus laevis oocyte; l-lactate

Mesh:

Substances:

Year:  2019        PMID: 31593685     DOI: 10.1016/j.bbamem.2019.183068

Source DB:  PubMed          Journal:  Biochim Biophys Acta Biomembr        ISSN: 0005-2736            Impact factor:   3.747


  2 in total

Review 1.  Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs).

Authors:  Johanna Huttunen; Santosh Kumar Adla; Magdalena Markowicz-Piasecka; Kristiina M Huttunen
Journal:  Pharmaceutics       Date:  2022-06-10       Impact factor: 6.525

2.  Autoregulation of H+/lactate efflux prevents monocarboxylate transport (MCT) inhibitors from reducing glycolytic lactic acid production.

Authors:  Wiktoria Blaszczak; Hannah Williams; Pawel Swietach
Journal:  Br J Cancer       Date:  2022-07-15       Impact factor: 9.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.